Compare IMUX & DTCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMUX | DTCX |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.8M | 83.5M |
| IPO Year | N/A | N/A |
| Metric | IMUX | DTCX |
|---|---|---|
| Price | $0.63 | $1.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 406.4K |
| Earning Date | 02-14-2026 | 02-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $1.51 |
| 52 Week High | $1.39 | $4.99 |
| Indicator | IMUX | DTCX |
|---|---|---|
| Relative Strength Index (RSI) | 48.52 | N/A |
| Support Level | $0.64 | N/A |
| Resistance Level | $0.71 | N/A |
| Average True Range (ATR) | 0.05 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 57.76 | 0.00 |
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
Datacentrex Inc maintains a digital asset treasury composed of assets generated through its mining hashrate, including Dogecoin (DOGE), Litecoin (LTC), and Bitcoin (BTC).